Article Details

Independent from Merck, Organon CEO lays out newco's women's health ambitions, M&A plans

Retrieved on: 2021-06-03 04:07:30

Tags for this article:

Click the tags to see associated articles and topics

Independent from Merck, Organon CEO lays out newco's women's health ambitions, M&A plans. View article details on hiswai:

Excerpt

The global women's health market is projected to be worth $50 billion by 2025, according to CB Insights. Ali pointed to the high 40% to 45% unintended ...

Article found on: www.fiercepharma.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up